Skip to main content
Livermore
Livermore
ZHEN

SG Americas Securities, LLC

SEC CIK
0001313360
Latest filing
Aug 7, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
427,703
Value
$266.7M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of REGN by SG Americas Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026427,703$266.7M0.2%+269,425+170.2%AddedHolders
Q1 2026158,278$122.3M0.1%+27,166+20.7%AddedHolders
Q4 2025131,112$101.2M0.1%+118,690+955.5%AddedHolders
Q3 202512,422$6.99M<0.1%−3,610−22.5%ReducedHolders
Q2 202516,032$8.42M<0.1%−48,031−75.0%ReducedHolders
Q1 202564,063$40.6M0.1%+62,122+3,200.5%AddedHolders
Q4 20241,941$1.38M<0.1%−21,414−91.7%ReducedHolders
Q3 202423,355$24.6M0.1%−17,056−42.2%ReducedHolders
Q2 202440,411$42.5M0.3%+29,901+284.5%AddedHolders
Q1 202410,510$10.1M0.1%+3,235+44.5%AddedHolders
Q4 20237,275$6.39M0.1%−16,866−69.9%ReducedHolders
Q3 202324,141$19.9M0.3%−20,021−45.3%ReducedHolders
Q2 202344,162$31.7M0.3%+17,037+62.8%AddedHolders
Q1 202327,125$22.3M0.3%+4,384+19.3%AddedHolders
Q4 202222,741$16.4M0.2%+10,452+85.1%AddedHolders
Q3 202212,289$8.47M0.1%+5,154+72.2%AddedHolders
Q2 20227,135$4.22M0.1%−1,167−14.1%ReducedHolders
Q1 20228,302$5.80M0.1%−1,598−16.1%ReducedHolders
Q4 20219,900$6.25M<0.1%+6,942+234.7%AddedHolders
Q3 20212,958$1.79M<0.1%−17,368−85.4%ReducedHolders
Q2 202120,326$11.4M0.1%+7,151+54.3%AddedHolders
Q1 202113,175$6.23M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.